Literature DB >> 2589029

Serum levels of antibodies against Actinobacillus actinomycetemcomitans in various forms of human periodontitis.

K Schenck1, S R Porter, T Tollefsen, J R Johansen, C Scully.   

Abstract

Serum levels of IgG, IgA, and IgM antibodies against extracts from Bacteroides gingivalis PER8, Actinobacillus actinomycetemcomitans Y4, and Bacteroides fragilis NCTC 9343 were determined in three categories of periodontitis patients by means of enzyme-linked immunosorbent assay. The test groups comprised 10 patients with juvenile periodontitis (JP), 18 young patients with severe periodontitis (YP), and 31 patients with adult periodontitis (AP). Nine subjects with healthy periodontium (HP) served as a reference group. Increased frequencies of patients with significantly elevated IgG and IgA antibody values against B. gingivalis and A. actinomycetemcomitans were found in the three periodontitis groups as compared with the HP group. The AP group, however, showed lower IgM values than the other groups. The results support the contention that A. actinomycetemcomitans may play a contributory role in adult periodontitis and that B. gingivalis is a suspected periopathogenic bacterium in juvenile periodontitis. The clinical YP classification was not supported by the present serologic findings.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2589029     DOI: 10.3109/00016358909007712

Source DB:  PubMed          Journal:  Acta Odontol Scand        ISSN: 0001-6357            Impact factor:   2.331


  3 in total

1.  Antigenically diverse reference strains and autologous strains of Actinobacillus actinomycetemcomitans are equally efficient antigens in enzyme-linked immunosorbent assay analysis.

Authors:  Tiina Vilkuna-Rautiainen; Pirkko J Pussinen; Kimmo Mattila; Marja Vesanen; Heidi Ahman; Başak Doğan; Sirkka Asikainen
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

2.  Initial serum antibody titer to Porphyromonas gingivalis influences development of antibody avidity and success of therapy for chronic periodontitis.

Authors:  J Mooney; E Adonogianaki; M P Riggio; K Takahashi; A Haerian; D F Kinane
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

3.  Opsonic antibody activity against Actinobacillus actinomycetemcomitans in patients with rapidly progressive periodontitis.

Authors:  K Sjöström; R Darveau; R Page; C Whitney; D Engel
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.